Monday, December 31, 2012

Top 10 Stock Picks for the New Year's Eve!

Happy New Year!

We bid farewell to 2012 and welcome the dawn of 2013 with good wishes and much success to our members, visitors and all the people around the world.

Our unique platform has been a success, during the year 2012 our membership has increased dramatically. Traders/investors are benefiting from our daily deals Everyday.

We would like to thank specially to those members who took the time to send us their feed back and valuable advice on how to improve our services, so members could benefit more. We always welcome your thoughts and comments.

We determine to continue to improvise and extend our offerings and bring more fresh deals to you. This unique platform wouldn't have been a success without your participation. Thank you.

Top 10 Stock Picks for the New Year's Eve!

    1.AAMC 2.LXRX 3.VICL 4.IDRA 5.ALVR 6.COOL 7.TBOW 8.PPHM 9.IDIX 10.AMRS

Get Top Picks at one place, Every Day, All Day!
Just Picks! We Pick You Decide!
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney

Wednesday, December 26, 2012

Best After Christmas Picks Ever! Our Top 10 Picks

Solar Stocks are having one of the best days of the year, most small cap solar stocks poised to gain.

Top 10 Picks from our Staff!

  1. YGE
  2. SOL
  3. HSOL
  4. LDK
  5. TSL
  6. STP
  7. CSUN
  8. JKS
  9. SPWR
  10. JASO

Happy Trading, Daily Stock Deals served Fresh Everyday!
Sign-Up and enjoy the Free benefits.

Happy Holidays!

Sunday, December 16, 2012

Stevia Corp (STEV) Provides Profit Guidance

Stevia Corp (STEV) Provides Profit Guidance

Company Expects to Generate First Quarterly Profit in 2013



INDIANAPOLIS, IN--(Marketwire - Dec 13, 2012) - Stevia Corp. ( OTCQB : STEV ) ("Stevia Corp" or the "Company"), a farm management company focused on the economic development of stevia, the fastest growing product in the alternative sweetener sector, is pleased to announce the expansion of its commercialization phase and first major crop harvest expected in Vietnam during first quarter of 2013.
Stevia Corp expects crop harvests in Vietnam to top 1,000 tons by March of 2013. Based on its forecasted sales price and costs, the Company believes this will produce more than $2 million of revenue and its first quarterly profit. This follows the first revenue reported by the Company this year of $112,517 for the quarter ended September 30, 2012.
George Blankenbaker, Stevia Corp President, comments, "This will again signify another major milestone achieved well ahead of schedule. This, together with our joint venture operations in China launched last quarter, will begin a solid foundation for the company to continue scaling its business model and target significant revenue and profit growth during calendar year 2013 provided we also achieve certain capital requirements."
Mr. Blankenbaker also added, "Now that we are well into our commercialization phase, we also have plans to update our website and provide a picture gallery and possibly a blog so that the public can more easily track our developments and experience our growth with us. We are excited about the rapid pace of developments and believe it is important to involve our shareholders. We expect to complete the first phase in January, so this is something that our investors can also be looking forward to for the New Year."
Further details of the Company's business, finances, appointments and agreements can be found as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database. For more information visit: www.steviacorp.us.
About Stevia Corp. ( OTCQB : STEV )
Stevia Corp. is a farm management company focused on best practice agronomic competency in order to deliver high-value stevia through proprietary plant breeding, excellent agricultural methodologies and innovative post-harvest techniques. To date, the Company has acquired two grower supply contracts and three nursery fields in Vietnam. For more information visit: www.steviacorp.us.

About the Stevia Industry SectorWithin two years of the USA market opening, Nielsen-based retail consumption data indicated almost $1 billion of retail sales for the sector. In 2010, stevia products were launched across thirty-five countries and in 38 categories. Zenith International estimates worldwide sales of stevia extract reached 3,500 tons in 2010 with an overall market value of $285 million and forecasts the global market for stevia will reach 11,000 tons by 2014 requiring the tripling of stevia leaf production at the farm level to keep pace with consumer demand. For more information visit: www.steviacorp.us.
Please read Disclosure/Disclaimer Daily Stock Deals read Research Report

Wednesday, October 24, 2012

Stevia Corp, STEV, Profile, Summary

Stevia Corp. | STEV | Profile | Summary

Stevia Corp. (STEV) is a farm management company focused on Stevia agronomics from plant breeding to good agricultural practices to development of stevia derived products.

Stevia Corp. invests heavily in R&D and IP acquisition and manages its own propagation, nursery, and plantations as well as provides services to contract growers and other industry growers.

The Company was founded to deliver top quality agribusiness solutions in order to maximize the efficient mass production of stevia leaf and stevia derived products. The Company is headquartered in the US with farm operations/R&D in Vietnam, China, and Indonesia and planned operations in the US.
Read the comprehensive analysis: find out the 'Target Price', market dynamics, the opportunity and meet the excellent management team click here , download the full report!


INVESTMENT HIGHLIGHTS

Opportunity to invest in an early development stage, vertically-integrated stevia farm management company in an emerging, high growth market

The Company plans to be a “one stop shop” agribusiness solutions provider offering the full spectrum of farm management services

o Operate its own plantations, manage contract farms, and service industry growers (read Executive Summary)
o Expects to achieve positive EBITDA by the second quarter of 2013, growing to $3mm in annualized EBITDA by the end of 2013
o Positioned to become a global leader in the stevia industry that maximizes the efficient mass production of stevia leaf and stevia derived products
o Fastest growing product in the alternative sweetener market with 6,000 products across 35 countries
o Expected to eventually replace 20% of the sugar segment of global sweeteners or a $10 billion market opportunity


Our valuation analysis results in a target price of $1.20 per share which represents significant upside of over 4 times the current stock price (see Valuation)

The Company recently secured $500,000 in an equity private placement
and has access to $20 million from Southridge Partners.

Global sweetener market is a $60 billion dollar industry! See the company's growth plans, the advantages of Vertically Integrated Supply Chain and much more...full free report

MANAGEMENT TEAM

Strong Global Executive Team with highly recognized leadership skills, expertise and decades of experience in Three Continents, Four vibrant economic regions of the world (The United States, Europe, Latin America and Asia-Pacific).

George S. Blankenbaker (President)
Mr. Blankenbaker has been leading the development of high Reb-A Stevia farming in Vietnam, where he imported the Morita variety to trial in 2008 and in 2009 signed a contract to supply stevia leaf to PureCircle, the industry's leading refiner. Mr. Blankenbaker first became involved in commercial agriculture in 2002 when he began working with the Agri-Food Veterinary Authority of Singapore (AVA) to provide strategically important food supplies to Singapore. Prior to that Mr. Blankenbaker co-wrote and co-presented a bid for the U.S. Navy Subsistence Prime Vendor (SPV) Contract valued at USD $197 million covering three zones of Japan, Singapore, and Diego Garcia. The contract was awarded in 2002 and the Singapore and Diego Garcia portion is currently supported by the Rong-Yao group, a partner company based in Singapore.

During the 1990s Mr. Blankenbaker was the Managing Director of a foodservice equipment company servicing South East Asia and was a partner of a holding company that established the first broadline foodservice distribution facility in Singapore which was also the first food distribution facility in Singapore to achieve both ISO 9000 and HACCP certification. Mr. Blankenbaker also traded commodities and was an independent consultant and analyst for Standard Chartered Bank and Reuters and was on the implementation team that established Globex in Singapore linking the Singapore International Monetary Exchange with the Chicago Board of Trade. Read more...

Rodney L. Cook (Director)

Dr. Pablo Erat (Director)

Thomas Ong (Director of Operations, Asia)

Dr. Zhang Ji (Chief Technical Advisor)

Dr. Nguyen Van Dan
(Technical Advisor – Vietnam R&D and Propagation Center)

Vincent Tan Meng Sheong (Director of Operations, China)

click here for Management Bios


Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoneywe received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Wednesday, September 26, 2012

Yukon-Nevada Gold,YNG,YNGFF, Profile, Summary

Yukon-Nevada Gold| YNG |YNGFF | Profile | Summary

Yukon-Nevada Gold Corp is listed on the Toronto Stock Exchange (YNG.TO)
and trades on the OTC/Pinksheets under the symbol YNGFF.

Jerritt Canyon, the Company's flagship project, is located in northern Nevada. The Company is currently focused on modernizing the milling facility and emission control systems. The Company is striving to reach a point of renewed profitability accompanied by a significantly reduced environmental impact. Ongoing permitting at Starvation Canyon, Nevada will allow the Company, in the future, to realize an increase in the production of gold ounces at Jerritt Canyon.

The Company is focused on bringing its wholly owned Ketza River property back into production from the Manto Gold Zones and permitting is underway. The Ketza River Property includes the Ketza River mine, which, from 1987 to 1990, produced 98,000 oz of gold and by-product silver from 340,000 tons of ore.


    1. Jerritt Canyon - historical production of approximately 8 million oz gold since 1981
+ 100% owned.
+ Permitted and Producing.
+ Current Reserve & Resource includes: 374,800 oz Proven, 686,000 oz Probable, 1.03M oz Measured & 1.29M oz Indicated.
+ Mill engineered capacity of 6,000 tpd of which 5,280 tpd is currently permitted.

    2. Ketza River - historical production of 98,000 oz of gold and by-product silver between 1988 - 1990
+ 100% owned.
+ Current Resource includes: 29,000 oz Measured and 388,700 oz Indicated.
+ Site infrastructure well developed.
+ Permitting in progress for mine/mill re-start.

Deutsche Bank invested $40M in equity and $140M gold forward sale.


Planned mine includes 9 open pits and
2 underground declines

+ 83% of the oz to be mined will come from the open pits.
+ Estimated mining rate of 50,000 tpd for the first 2 years and 20,000 tpd in the 3rd year from the open pits.
+ An additional 500 tpd will come from underground mining.

A total of 41% of the measured and indicated recoverable resource ounces are hosted in oxide ores which have a gold recovery of 90%; whereas the other 59% of the measured and indicated recoverable, resource ounces are hosted in sulfide or mixed sulfide+oxide ores that generally have Au recoveries of 70%.

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoneywe received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Saturday, September 8, 2012

HOKU, Hoku Corporation, Profile, Summary

Hoku Corporation | HOKU | Profile | Summary
Hoku Corporation (HOKU) is a solar products and services company operating two businesses: Hoku Materials and Hoku Solar. Hoku Materials manufactures, markets and sells polysilicon for the solar industry from its plant currently under construction in Pocatello, Idaho. Hoku Solar is a leading provider of commercial solar power, offering turnkey PV systems and project development services.

Hoku Solar
Hoku Solar – HOKU - is a leading provider of investment-grade solar power, offering project development services, turnkey PV system integration and asset management for solar energy facilities.
Hoku Solar focuses primarily on the commercial and industrial solar market segment, providing large-scale rooftop or ground-mounted PV arrays for businesses, institutions and government clients. We have proven experience with specialty and technical solar products, including third party financed purchase power agreements (PPAs), and building integrated PV. Hoku is also increasingly engaged in the multi-megawatt utility scale market, both as a project developer and as an EPC service provider.
Hoku Solar is active in Hawaii, and is expanding its project development business to other U.S. markets.
Hoku Solar Services

Turnkey PV Integration
Hoku Solar is a full-service solar industry EPC contractor, providing its customers with turnkey engineering, procurement, and construction services for investment-grade PV.

Hoku Solar primarily serves commercial and industrial rooftop customers, large real estate portfolio holders and developers, general contractors, and government and institutional clients.

With proven experience in the Hawaii market, Hoku can deliver a full range of commercial systems, ranging from individual rooftop arrays to multi-megawatt ground-mounted systems.
Project Development
With our unique design and development service offering, Hoku Solar is positioned to bring large-scale and portfolio PV projects to life, whether as lead developer, or as a complement to an existing project team.
Hoku Solar has proven experience at every stage of the PV development cycle – from feasibility studies to commissioning and take-out financing – and we tailor our services to the individual needs of the project. So, whether Hoku is leading the development itself, or contributing to a broader effort, we are focused on scaling up solar in the U.S.
Contact us today and let us put our experience to work for you.
Asset Management
Underperforming solar arrays are underperforming investments. Hoku Solar has the engineering, technical and operational experience to help ensure your target returns are achieved.

We offer customized operations and maintenance programs for a wide variety of commercial systems, each designed to enhance overall system performance and reliability. From system assessment to preventative and corrective maintenance and monitoring, let Hoku Solar’s asset management team help guarantee your PV system’s long-term performance.
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!® we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.
If you want to get your company profiled or have any questions, please don't hesitate to contact the Editor [@ ] OxBridgeResearch.com

Sunday, September 2, 2012

Romney's Tax Secret Revealed! How to Convert Ordinary Income into Capital Gains.

The New York attorney general is investigating whether some of the nation’s biggest private equity firms have abused a tax strategy in order to slice hundreds of millions of dollars from their tax bills, according to executives with direct knowledge of the inquiry.
Enlarge This Image

Andrew Harrer/Bloomberg News
The Washington office of the Carlyle Group, which The Carlyle Group has stated in regulatory filings that their partners have not diverted management fees into investments in their funds.
Enlarge This Image

Evan McGlinn for The New York Times
Bain offices in Boston. According to financial statements, Bain partners saved more than $200 million in federal income taxes and more than $20 million in Medicare taxes.
Readers’ Comments
Share your thoughts.
Post a Comment »
Read All Comments (218) »
The attorney general, Eric T. Schneiderman, has in recent weeks subpoenaed more than a dozen firms seeking documents that would reveal whether they converted certain management fees collected from their investors into fund investments, which are taxed at a far lower rate than ordinary income.
Among the firms to receive subpoenas are Kohlberg Kravis Roberts & Company, TPG Capital, Sun Capital Partners, Apollo Global Management, Silver Lake Partners and Bain Capital, which was founded by Mitt Romney, the Republican nominee for president. Representatives for the firms declined to comment on the inquiry.
Mr. Schneiderman’s investigation will intensify scrutiny of an industry already bruised by the campaign season, as President Obama and the Democrats have sought to depict Mr. Romney through his long career in private equity as a businessman who dismantled companies and laid off workers while amassing a personal fortune estimated at $250 million.
Some executives at the firms said they feared that Mr. Schneiderman, a first-term Democrat with ties to the Obama administration, was seeking to embarrass the industry because of Mr. Romney’s roots at Bain. Others suggested that the subpoenas, which were issued by the attorney general’s Taxpayer Protection Bureau, might be part of an effort to recover more revenue for New York under state tax law. The attorney general’s office does not have the power to enforce federal tax laws.
A spokesman for Mr. Schneiderman declined to comment.
The tax strategy — which is viewed as perfectly legal by some tax experts, aggressive by others and potentially illegal by some — came to light last month when hundreds of pages of Bain’s internal financial documents were made available online. The financial statements show that at least $1 billion in accumulated fees that otherwise would have been taxed as ordinary income for Bain executives had been converted into investments producing capital gains, which are subject to a federal tax of 15 percent, versus a top rate of 35 percent for ordinary income. That means the Bain partners saved more than $200 million in federal income taxes and more than $20 million in Medicare taxes.
The subpoenas, which executives said were issued in July, predated the leak of the Bain documents by several weeks and do not appear to be connected with them. Mr. Schneiderman, who is also co-chairman of a mortgage fraud task force appointed by Mr. Obama, has made cracking down on large-scale tax evasion a priority of his first term.
As a retired partner, Mr. Romney continues to receive profits from Bain Capital and has had investments in some of the funds that documents show used the tax strategy.
The campaign issued a statement saying that Mr. Romney did not, however, benefit from the practice. “Investing fee income is a common, accepted and totally legal practice,” said R. Bradford Malt, a lawyer for Mr. Romney who manages his family’s investments and trusts. “However, Governor Romney’s retirement agreement did not give the blind trust or him the right to do this, and I can confirm that neither he nor the trust has ever done this, whether before or after he retired from Bain Capital.”
Managers at a typical private equity firm or hedge fund collect from their investors management fees based on the size of the fund. But most of their compensation comes as a share of the profits earned by the fund. The Internal Revenue Service allows those profits to be considered “carried interest,” taxed at the capital gains rate typically reserved for investments.
The tax strategy used by Bain and other firms to convert management fees — the compensation normally taxed as ordinary income — into capital gains is known as a “management fee waiver.” The strategy is widely used within the industry: 40 percent of the 35 buyout firms based in the United States surveyed in 2009 by Dow Jones said their partners used at least some of the firm’s fees to make investments in their funds.
But some prominent firms appear to avoid the practice. The Carlyle Group and Blackstone Group have stated in regulatory filings that their partners have not diverted management fees into investments in their funds.
In the varied world of private equity, some firms may have lawyers who are not aware of the strategy or have steered their clients away from it, said a lawyer at one firm who has used the strategy for his clients. Others, he said, may not have the operational capabilities to handle the complex transactions.
Apollo Global Management, the buyout firm co-founded by Leon Black and now publicly traded, is among those that use the conversion strategy. Between 2007 and 2011, Apollo converted more than $131 million in fees into investments in its funds, according to S.E.C. filings. A spokesman for the firm declined to comment.
Likewise, K.K.R. converted more than $180 million in fees between 2007 and 2009, according to its filings. Kristi Huller, a spokeswoman for the firm, declined to comment about any regulatory matter, but said in an e-mail that K.K.R. had not used the tax strategy “for the past few years.”
Other firms that received subpoenas include Clayton, Dubilier & Rice; Crestview Partners; H.I.G. Capital; Vestar Capital Partners; and Providence Equity Partners. Representatives for all these firms declined to comment.
Tax lawyers have justified the arrangements by arguing that converting the management fees into carried interest, which could lose some or all of its value if a fund does poorly, entitles the managers to the lower capital gains rate, which is intended to help mitigate the risks taken by investors.
“They’re risking their management fee — they’re giving up the right to that management fee in any and all events,” said Jack S. Levin, a finance lawyer whose firm has represented Bain on some matters. Mr. Levin said he did not consider the practice risky or even aggressive.
“The I.R.S. has known that private equity funds have been doing this for 20 years,” he said.
In 2007, the agency began taking a closer look at suspected tax abuses at hedge funds and private equity firms. In a statement at the time, an I.R.S. spokesman said that management fee conversions were among several “areas of possible noncompliance.” But no formal ruling appears to have emerged.
Some private equity firms take what tax experts consider a less aggressive approach to the conversions, waiving fees on all of a given fund’s investments over the lifetime of the fund, which can be 10 years.
But other firms choose which funds or even which particular investments to waive fees on frequently, like every year or every quarter. Such arrangements may allow the executives to apply the waiver only when they believe their funds are more likely to appreciate in value, substantially reducing their investment risk.
Mr. Schneiderman is also looking at whether private equity executives treated management fees as a return of invested capital — potentially escaping taxation entirely — or deferred payouts of the converted fees in ways that improperly reduced their tax liabilities.
Executives at three of the firms subpoenaed by Mr. Schneiderman, who asked for anonymity because they were bound by confidentiality agreements, said that disclosures to their investors clearly stated that the waived fees were allocated equally to all the investments in a fund.
The leaked documents show that Bain has in recent years waived management fees in at least eight private equity and other funds, including one formed as early as January 2002. The documents stated that Bain executives had the right to decide either annually or each quarter whether to waive some or all of their management fees; they also had the ability to convert the waived fees into investments in particular companies held by the funds.
Victor Fleischer, a law professor and finance expert at the University of Colorado who has been critical of the tax rules for private equity firms, said he believed Bain had waived management fees into investments with so little risk that the arrangement would not qualify for the capital gains rate if challenged by the I.R.S.
“There is a tension between economic risk and tax risk that is supposed to be inversely proportional,” Mr. Fleischer said. “The way Bain set it up there’s not much risk at all, so it’s hard to see how this income should receive capital gains treatment.”

Michael Luo contributed reporting.
Courtesy: New York Times
OxBridgeResearch

A123 Systems, AONE, Profile, Summary

A123 Systems |AONE | Profile | Summary

A123 Systems – AONE - develops and manufactures advanced Nanophosphate® lithium iron phosphate batteries and energy storage systems. The company’s technology enables customers to commercialize innovative products for the transportation, electric grid, commercial and government markets.

A123's proprietary Nanophosphate technology is built on novel nanoscale materials initially developed at the Massachusetts Institute of Technology. The company has spent more than $2 billion dollars on development and large scale manufacturing plants with global ambitions.
IronPhosphate Battery Technology
A123’s high-performance Nanophosphate® lithium iron phosphate (LiFePO4) battery technology delivers high power and energy density combined with excellent safety performance and extensive life cycling in a lighter weight, more compact package. Our products have low capacity loss and impedance growth over time, allowing our systems to meet end-of-life power and energy requirements with minimal pack oversizing.
Lithium Ion Battery Technology
A123’s next-generation Nanophosphate EXT™ lithium ion battery technology improves power capability at low temperature and life at high temperature, potentially reducing or eliminating the need for costly thermal management.
By extending the capabilities of our core Nanophosphate® technology over a wider temperature operating range, Nanophosphate EXT is expected to deliver increased performance and reliability while minimizing complexity and reducing total cost of ownership (TCO) over the life of the battery system for a number of applications, including micro hybrid vehicles, electric vehicles, telecommunications backup and military systems, among others.
Energy Storage Systems
A123 Systems excels at designing and manufacturing fully-integrated battery systems that help enable our customers to take new products from concept to commercialization. A123 has extensive engineering experience in developing and implementing advanced components, software, electronics, thermal management and battery management systems for innovations in battery system design. We provide complete system design and integration services and develop optimized systems that meet our customer’s performance requirements, including power, safety, life, and energy, while meeting size, weight and cost targets.
The Opportunity
The recession in the United States and European Economic crisis resulted in slower than expected demand for the Electric Vehicles. The company is poised to benefit when the global economic conditions improve, it has invested hundreds of millions in R&D and established long term relationships with leading OEMs and built a network of charging stations.
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Hemispherx Biopharma, HEB, Profile, Summary

Hemispherx Biopharma | HEB | Profile | Summary
Hemispherx Biopharma (HEB) is a biopharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of viral and immune-based disorders. Hemispherx’s flagship products include Alferon N Injection® and the experimental immunotherapeutics/antivirals Ampligen®.
Hemispherx’s platform technology includes large and small agent components for potential treatment of various severely debilitating and life threatening diseases. Hemispherx has an extensive number of patents comprising its core intellectual property estate and a fully commercialized product (Alferon N Injection®). The Company wholly owns and exclusively operates a GMP certified manufacturing facility in New Brunswick, New Jersey.

ALFERON
Alferon N Injection® is the company's registered trademark for its injectable formulation of Natural Alpha Interferon, and is approved by the FDA for a category of STD infection.  Alferon N Injection® (interferon alfa-n3 human leukocyte derived) is a highly purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon.
Alferon LDO® (Low Dose Oral) is a new experimental drug delivery platform for the Company’s highly purified, natural source alpha interferon.
ALFERON N Injection® is the only highly purified, natural-source, multispecies alpha interferon product currently sold in the U.S. and is also approved for sale in Argentina.
Clinically Effective:
All warts disappeared in 54% of patients.3
No recurrence in 76% of complete responders at follow-up.3
Completely cleared 73% of all treated warts.3,4
No human antibodies to interferon alfa-n3 detected in clinical trails.3,4
Provides a spectrum of multiple alpha interferon subtypes.1,

What's in the Pipeline?
Ampligen® (poly I:poly C12U) is a synthetic specifically configured double-stranded RNA containing regularly occurring regions of mismatching.  Ampligen® and Oragens® experimental nucleic acids are being developed for the potential treatment of globally important viral diseases and disorders of the immune system including HPV, HIV, Chronic Fatigue Syndrome (CFS), Hepatitis and influenza.

Watch This!
On July 31, 2012 Hemispherx submitted its complete response to the FDA’s Complete Response Letter in support of Ampligen®’s New Drug Application for Chronic Fatigue Syndrome (“CFS”).
Its too early to tell what the FDA's response would be, however, the response from investors has been very positive. We alerted our members and followers last week and we believe this company should be on your radar!
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Sunday, July 1, 2012

Epic, EPOR, Market Summary, Profile

Epic (EPOR) Market Summary

Epic is a publicly traded company, since its founding in 1997, the company has focused on Research and Development of Healthcare products. Epic's goal is to make a meaningful difference in the lives of millions of Americans who are suffering from chronic pains. (Note:-OxBridge has just released a comprehensive Marketing Intelligence Report on EPOR) see the full Report

AcuFABTM
The company has successfully developed a specially engineered fabric called AcuFABTM, which improves blood circulation to the pressure points and sore joints, providing great comfort and relief from chronic pains.

EPIC sells 'the fabric' to the Original Equipment Manufacturers (OEMs), these manufacturers make, various products using the AcuFabTM, and sell directly to consumers and healthcare institutions under their own Brand names.

AcuPADTM
EPIC also makes its own Branded products, with AcuFABTM, under the name AcuPADTM. AcuPADs are sold directly to healthcare institutions and consumers through the company's website www.epiccor.com, Amazon.com and other distributors.

Business Model
Epic’s business model is similar to Intel’s famous “intel inside” model, where Intel supplies CPUs to companies like Dell and HP and these OEMs incorporate intel’s technology into their PCs and Laptops.

The Opportunity

Epic Corporation has a proprietary and patent protected manufacturing process for a fabric solution which offers great advantages to the surface tissue. In a world where we have major problems with sedentary lifestyles, poor eating habits, and healthcare issues, these solutions may be the answer for patients everywhere. What is most intriguing is that these products have some technological barriers to entry yet do not have to go through the rigorous FDA approval process.

Epic's Solutions for Healthcare Crisis

American healthcare system is under severe strain and the healthcare costs are rising rapidly, Obesity and Diabetes increasing dramatically due to diet and sedentary life style. EPIC’s preventative solutions for chronic pains could provide relief from pain and financial burden. read the full Report

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney
we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Wednesday, June 6, 2012

Entree Gold, EGI, Summary, Profile

Entree Gold | EGI | Summary | Profile

Entrée Gold (EGI) is a Canadian mineral exploration company focused on the worldwide discovery and development of copper and gold prospects. The Company has significant interests in three key copper porphyry deposits: the Hugo North Extension and the Heruga deposits in Mongolia, and the Ann Mason deposit, located near Yerington, Nevada.

The Lookout Hill property in Mongolia completely surrounds the Oyu Tolgoi mining, a subsidiary of Ivanhoe Mines and the Government of Mongolia.

The Company is also exploring for porphyry-related copper systems in Nevada and New Mexico. The primary North American asset is the Ann Mason Project, located near Yerington, Nevada.
The Yerington copper camp has seen significant historic copper production along with a resurgence of exploration activity and now hosts over 20 billion pounds of copper in several deposits owned by a diverse group of companies.

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!® we received or expecting compensation from the featured company or a third party. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Wednesday, May 23, 2012

DailyStockDeals.com (Urgent Market Alert) Daily Stock Deals Makes a Bold Market Call, Members and Followers rack up huge Gains, 130 Point Move in DOW, NASDAQ in Positive Territory!

6m Daily Stock Deals ‏@TOP10STOCKS
100 Point MOVE! on RECORD, check out the Time-Line http://www.dailystockdeals.com/ NASDAQ turns + what a Market Call! WoW #NASD #top10picks #DOW #ETF

22m Daily Stock Deals ‏@TOP10STOCKS
$DOW $NASDAQ $S&P are NOT exactly Penny Stocks.Did we Make the Right Market Call? Thanks for Tweets & Emails!http://www.dailystockdeals.com/
58m Daily Stock Deals ‏@TOP10STOCKS
REPEAT! MARKET CALL! $DOW $S&P $NASDAQ all poised for a turn around! Pivotal Move! http://www.dailystockdeals.com/ #dow #nasdaq #top10picks #alerts
1h Daily Stock Deals ‏@TOP10STOCKS
$DOW $S&P $NASDAQ all poised for a turn around! Pivotal moment in the Market! http://www.dailystockdeals.com/ #dow #nasdaq #top10picks #alerts

Monday, May 7, 2012

OxBridgeResearch –Stock Market News- Gold Stocks to Watch, Emgold Mining, EMR.V, EGMCF.PK

Stock to Watch!
Emgold Mining Corp. EMR (TSX.V) EGMCF (OTCQB)
Emgold Mining Corporation is a gold exploration and development company with five exploration and development projects in North America. The Company is focused on acquiring and developing quality properties, and advancing them through exploration, permitting, construction, and ultimately create a new gold producing company.
Focus
The Company is focused on reopening the historic Idaho-Maryland Gold Mine located in Grass Valley, California. The Company plans to develop a 2,400 ton per day mining operation with potential to produce over 200,000 ounces of gold per year.
Additional Properties
Emgold Mining also has a portfolio of four early to middle stage mineral exploration projects including the Buckskin-Rawhide Property, and the Koegel Rawhide Property in Nevada, the Stewart Property, and the Rozan Property in British Columbia.
INVESTMENT HIGHLIGHTS
Opportunity to invest in a world class gold asset whose main property has potential to develop a 3-5 million ounce gold resource.
Idaho-Maryland Project in California has significant gold resources and production potential
Measured & Indicated: 472,000 ounces of gold. Inferred: 1,002,000 ounces of gold.
Company planning to produce over 200,000 ounces of gold annually.
13 million ounces of gold was produced within 3 mile radius, see why Emgold's has been involved with this property since 1993!
Four additional excellent exploration properties in Nevada and British Columbia. Learn more about these great properties.
The Company’s gold assets and solid resource base seems to be currently undervalued with the stock trading at $0.10 per share, implied value per ounce of only $4 per ounce of gold. See the Valuation
The Company successfully raised $2.2 million and planning to raise additional funds to advance Idaho-Maryland project.
Strong management team and Board of Directors with considerable exploration and development experience. meet the Management Team!
Find out the 'Target Price', read the compelling analysis.
Full Report is now available for FREE! download now.
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
we received or expecting compensation from the featured company or a third party. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Wednesday, April 18, 2012

DailyStockDeals.com -Stock News- SNPK at inflection point. Today is the Day! See why 2 things matter the most

The Meteoric Rise of SNPK

The stock has been going up 10% or more everyday.
The stock could take a big hit if it couldn't pass through
the psychologically very, very critical milestone of One
Billion Dollar!

Two important things to watch:

1). If the stock fails to achieve $1 Billion Market Cap.
2). Fails to cross the critical $2.50 hurdle today.

It might pause right here and/or you may see profit taking.
To our Members and Followers: you heard it here first, make a note to yourself.

Happy trading!
DailyStockDeals.com

Monday, April 16, 2012

OxBridgeResearch - stock market news - Vitamin stock on Steriods! SNPK, Sunpeaks Venture, Clotamin

This little Vitamin supplement stock has been on Steroids! The stock has risen dramatically from @ 40 cents to $1.80. The company is now worth a whopping $760 Million Dollars! How far the stock could go and for how long? Find out Today!
For our Busy Readers, we present A Quick Snap Shot of SNPK!

SNPK 's stellar announcements:
Latest News:  SNPK signs advertising and promotion agreement with another major sports team. Clotamin to be sold in all 240 Walgreens locations across Arizona!
SNPK entered agreement with a UK based heathcare firm to introduce Clotamin to the UK and European Union countries. This was another great move by the company to grab market share in countries across the pond!
SNPK receives $9 price target, and STRONG BUY recommendation by Small Cap Investment Research.
SNPK (in a first move to expand to international markets) announced an LOI to export Clotamin to top pharmacies in Russia. The initial roll out will be into 414 Imperia-Pharma locations in the country. This news is absolutely gigantic, and will attract foreign investors' interest in SNPK!
SNPK  Inks Sponsorship and Marketing Agreement with Portland Trail Blazers, Clotamin to be sold at 79 Walgreens locations throughout Oregon and Southern Washington. This news is very welcome as it shows us that the company is not only expanding rapidly in the south east, but also throughout the country as it looks to gain critical mass for Clotamin!
SNPK  announced that the AACSA could carry Clotamin into up to 11,200 stores in the next 36 months! With 1,200 stores "trial" to start shortly!
SNPK  announced a sales and marketing agreement with Acosta is a major milestone for  SNPK  because Acosta has developed relationships with the nation's largest retailers. With $50 billion in system-wide sales and nearly 20,000 associates that monthly call on over 100,000 retail stores per month Acosta is a key player in the industry and has a monster list of clients that include Walmart, Campbell's, Procter & Gamble!
SNPK  announced that Clotamin will be available at 57 Winn-Dixie stores across South Florida. This news is absolutely fantastic because the Winn-Dixie group (with parent company) operates almost 1,000 stores throughout America and after rolling out Clotamin into the initial 57 stores the product may have a great chance of being sold at additional locations in their network. For those of you who don't know the Winn-Dixie stores had over $7 billion in revenue in 2010 so this announcement is gigantic.
SNPK  announced that Clotamin is now available online nationwide at Walgreen's. We aren't even going to comment about this announcement as everyone knows fairly well how enormous Walgreens is and just how huge this news is. In fact you can go to Walgreens online right now and order Clotamin if you need it! It's only 25.99!
SNPK  announced that Clotamin will be sold at Tropical supermarkets in South Florida.
SNPK  announced that Clotamin will be sold at Bravo supermarkets in South Florida.
SNPK  announced that Clotamin will be sold at approximately 70 Drug Mart locations in Ohio. Being carried by Drug Mart in Ohio is amazing for SNPK as it begins expanding outside of the Florida and into retailers nationwide.
SNPK 's clotamin will also be sold at over 34 Sedano's stores in Florida. Sedano's is the No. 1 Hispanic owned retailer in the US, and is also the largest member of the Associated Grocers of Florida. This in itself is a huge achievement for Clotamin as it pierces in the Latin American market.
SNPK  announced that Clotamin will be sold at Navarro Discount Pharmacies.
SNPK  announced that Dakota Drug Inc. is a distributor for Clotamin. This milestone is very important as these key distributors can dramatically increase Clotamin's presence in the marketplace.

Courtesy: Ox of Wall street
OxBridgeResearch.com

Saturday, April 14, 2012

Ecosphere Technologies, ESPH.OB, Summary, Profile

Ecosphere Technologies | ESPH.OB | Summary | Profile

Ecosphere Technologies, ESPH.OB, is a diversified engineering and technology company, engaged in clean technologies and services.

The company designs and builds mobile water filtration equipment, waste water treatment and provides water recycling services to the energy exploration companies.

Ozonix®

The company's patented Ozonix technology is primarily used by the gas and oil companies for treatment and recycling of water used in fracking. The technology eliminates, bacteria and reduces scaling, eliminating the need to dispose the contaminated water. This process helps Oil&Gas companies save money and improve productivity.

Mobile, High-Volume Fluid Reclamation:
Ozonix® Eliminates Liquid Chemical Biocides
Provides Rapid On-Site Water Reclamation
Oxidizes Contaminates, Killing Bacteria and Destroying Bacteria Cell Walls On-the-Fly
Eliminates Costly Biocides and Reduces Scale Inhibitors Needed for Corrosion Control
Eliminates the Costs Associated with Waste Separation, Transportation & Disposal
High-Volume Water Treatment Capabilities allow for Quick Turnaround Time and Increased Utilization
Self-Contained Ozonix® Systems offer Minimal Mobilization and Demobilization Arrangements
Environmentally Safe, Eliminating Hazardous Waste Byproducts and Residual Pollutants
Ozonix® Preserves Natural Water Resources Minimizing Customers' Carbon Footprints

The Shale Gas industry is expanding at a rapid pace, waste water treatment, recycling and chemicals used in the process of fracking is a major environmental concern. The company's has developed a technology that doesn't require any chemicals. The company has a great technology serving the growing need of Oil & GAS, Mining Industries and Municipalities, and an Excellent management team, Keep an eye!

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney
we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

OxBridgeResearch.com (DJ Newswires)Yuan trade band expands, US, Europe calls for more

-China will allow the yuan to trade in a wider daily range beginning Monday --Beijing moving gradually toward a more market-determined exchange-rate regime --Yuan's trading band against U.S. dollar now 1.0% above and below a daily reference exchange rate, from 0.5% now --White House calls move 'progress.' Will push for more movement with ultimate goal of reaching 'market value.' By Esther Fung and Shen Hong `Of DOW JONES NEWSWIRES SHANGHAI (Dow Jones)--China will allow the yuan to trade in a wider daily range against the U.S. dollar beginning Monday, taking another major but widely-anticipated step to further liberalize its exchange-rate regime and make its currency more market-oriented. The move received cautious praise by U.S. and international officials, who described the widening as an important step while renewing their calls for further appreciation of the yuan. The People's Bank of China said Saturday it will widen the yuan's trading band against the U.S. dollar to 1.0% above and below a daily reference exchange rate from 0.5% now. It last expanded the dollar/yuan trading band from 0.3% in May 2007. The move came at a time when the currency's immediate outlook seems murky and as pressures for the yuan to appreciate have eased substantially after recent data showed that the country's trade has become more balanced, ending a remarkable era of constant, huge trade surpluses as Chinese goods flooded the global market with the help of inexpensive labor and a cheap yuan. Senior officials, including Premier Wen Jiabao and China's central banker, have hinted strongly on various occasions in recent months that they would let the yuan trade in a wider range as they argued the currency is nearing fair value. The authorities' decision also followed data showing the world's second-largest economy grew at its slowest pace in three years in the first quarter, a development that calls for further policy easing. The yuan's performance has indeed become significantly more volatile in recent months, suffering waves of heavy selling and on numerous occasions hitting its downside band limit due to concerns about a hard landing for the Chinese economy. The yuan has depreciated 0.14% against the dollar so far this year and accumulated a gain of 8.3% since Beijing effectively depegged its currency from the greenback in June 2010. The yuan was trading at around 6.3030 to the dollar late Friday. more news

Thursday, April 12, 2012

Buy Sell Penny Stocks (press release) Google splits stock, creates new C shares, A shares retain Voting right

NEW YORK (AP) — Google Inc. has announced plans to issue a new class of stock to existing shareholders, effectively splitting shares 2 to 1. It’s an unusual approach that reflects a desire by Google’s founders to preserve the company’s long-term interests.
Here’s an explanation of the plan:
Q. Why is Google doing this?
A. Google’s current stock structure concentrates voting power with Google’s founders, Larry Page and Sergey Brin, and with Executive Chairman Eric Schmidt. Google is afraid of diluting that power as it issues new shares to employees and to companies that it acquires through stock purchases. Google says there’s no immediate danger of that happening, but it sees no need to wait. “It’s important to bear in mind that this proposal will only have an effect on governance over the very long term,” Page and Brin wrote in a letter. “It’s just that since we know what we want to do, there’s no reason to delay the decision.”

Q. What does this mean for existing shareholders?
A. Investors typically have Class A stock now. They will be given an equal number of Class C shares, which won’t have any voting power. The value of the Class A stock will be split between the two, so if the stock is trading at $600 when it happens, a Class A share will be worth $300 and a Class C share will be worth $300. Investors will have twice the number of shares they held before, but the total voting power and stock value won’t change. So if Bob owns 100 shares worth $600 each, he will own 200 shares worth $300 each. Bob will still have 100 votes, and the value of all his shares will still be $60,000. Investors will be free to buy and sell shares in either class independently, and the new class will get its own ticker symbol. If Bob sells his 100 Class C shares, he will have 100 votes through the Class A stock, and the shares will be worth $30,000. But if Bob sells his 100 Class A shares, he will have no vote on the Class C stock worth $30,000.

Wednesday, April 11, 2012

Is Sunpeaks Ventures, SNPK.OB, $625 million Valuation justified?

Sunpeak, SNPK, a tiny little 'vitamin' maker/distributor sporting a whopping $625 million dollars in market cap. All we have seen so far is a constant stream of press releases, announcing LOI from Russia and availability of vitamins at well known stores nationwide.

The company has not provided any sales figures yet! It would be very interesting to see the numbers match the hype.

Saturday, March 31, 2012

Marina Biotech, MRNA, Summary, Profile

Marina Biotech | MRNA | Summary | Profile
Marina Biotech – MRNA - is focused on the discovery and development of novel RNAi-based therapeutics in the area of oncology, bladder and liver cancer.

The company is exploring the potential of RNAi-based therapeutics through the development of multiple broad-based, state-of-the-art drug discovery platforms built upon industry leading expertise in RNA chemistry, microbiology and oligonucleotide delivery.
Bladder Cancer
Marina Biotech is conducting preclinical studies in bladder cancer utilizing our tauRNAi platform. Bladder cancer ranks as the 4th most common cancer in men, and the 9th leading cause of death in men in the US. Approximately 75% of all bladder cancer cases in the US are in men. In the US, it is currently estimated that on a yearly basis, more than 70,000 new patients will be diagnosed with bladder cancer and approximately 15,000 deaths will occur from bladder cancer.
Liver Cancer
Marina Biotech is utilizing the tauRNAi platform in preclinical studies of hepatocellular carcinoma, more commonly known as liver cancer. Leading causes of liver cancer include viral infection (hepatitis), toxins, and damage to the liver that result in cirrhosis. Worldwide there are more than 500,000 new cases of liver cancer each year. It is currently estimated that in the US, more than 20,000 new cases of liver cancer will be diagnosed and 19,000 deaths are expected to occur due to liver cancer.

The company has partnered with World's leading companies and universities, including University of Michigan and University of Helsinki. The partners include Roche and Novartis.

The stock is trading near 52WK LOWS, may bounce back keep an eye!
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Monday, March 19, 2012

Premier Beverage, PBGC, Profile, Summary

Premier Beverage | PBGC | Profile | Summary

Premier Beverage Group (PBGC.PK ) develops and distributes functional beverages (energy drinks/energy shots) and vitamin enhanced waters. The functional beverage category has has seen a dramatic rise in the last 5 years, disrupting the traditional soft drink market dominated by a few national brands.

OSO Beverages
Premier sells its drink under OSO brand, and trying to position itself as a premium energy drink to high profile on-premise accounts. OSO products are available in original and light flavors in an 8.4oz can.
Energy drinks have exploded in mass retail environments, on-premise accounts have been forced to accept a mass retail product as the only energy drink on the market. Premier created a stand-out product that matched the high end surroundings of elite clubs and on-premise accounts.

Captive Brands
Captive Brands a Premier subsidiary offers a turnkey program for retailers from brand development to product manufacturing in return for an exclusive supply agreement and/or an ongoing royalty on sales of the products.
Captive brands are store brands that differentiate themselves based on brand versus solely price positioning – the next generation of “generics” or “private labels.” These brands are promoted head-to-head with national brands, receive premium shelf space, and generally are products that match national brands in terms of quality. Captive brand programs provide retailers with a comprehensive solution including brand development, product formulation, marketing, manufacturing, distribution and warehousing.

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Wednesday, February 15, 2012

FDA's surprise Valentine Gift to WOMEN!




FDA's surprise Valentine Gift to WOMEN!

Who says FDA doesn't know anything about romance? We are pretty sure nothing like this ever happened before, the greatest romantic gesture in the history of FDA and the timing was priceless!

On Valentine eve FDA delivered a surprise gift, Ladies: its NOT long stem Roses, something Better! FDA said YES! to Gel. FDA has approved BioSante's Bio-T-Gel. BPAX estimates the market for Male Dysfunction drugs in the US alone is $1.2 Billion Dollars.

We alerted our members on Jan 17th when the stock was trading near the 52WK Lows, our headline read “BPAX shareholders wonder if there is a Gel for stock dysfunction!”

Well, there you have it, FDA answered the prayers and BPAX is UP a whopping 107% ! our members are ecstatic. Are you Gellin'?

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
we receive compensation from companies we feature, Always Read the full Disclosure/Disclaimer. Thanks.

Thursday, February 9, 2012

DayStar Technologies | DSTI | Profile | Summary

DayStar - DSTI - is focused on low-cost, high performance, CIGS thin film photovoltaic products for converting electricity from the sun. The company aiming to achieve cost and performance parity with fossil fuel electricity generation.
Solar Photovoltaics
Solar cells work by absorbing light and converting it to electrical power, referred to as the photovoltaic effect. The majority of commercial solar cells in use today are made of silicon, the same semiconductor material used in the microelectronics industry. In addition to the semiconductor materials, solar cells consist of a top and bottom electrical contact to move the electricity out of the solar cell. The performance of a solar cell is measured in terms of its efficiency in converting sunlight into electricity. Typical commercial solar cells have an efficiency ranging between 6% and 18%, meaning that for every 1,000 watts of sunlight striking a solar module, 60 to 180 watts of electricity will be produced.
Thin Film Photovoltaics
Solar cells and modules made from certain thin film semiconductors have been shown to be much less expensive to produce in larger volume and requiring much less raw material to produce than silicon based PV cells. Extensive research and development on thin film cells has been conducted for more than 30 years, and recent advances in manufacturing and product commercialization have increased worldwide share of thin film photovoltaics to over 10% in 2007.
Thin film photovoltaic products exhibit the following attributes:
Scaleable, low cost manufacturing: Thin film solar cells and modules require a structural "substrate" to support them, such as glass. Applying the films on low cost glass substrates enables continuous and scaleable manufacturing. As much of the equipment to process these substrates is used in other industries, the capital expenditure required to establish large-volume thin film PV product manufacturing plants enables rapid capacity expansion and lowers the cost per watt of products.
Lower material cost: The substrate and raw materials used in thin film PV products are less expensive than the cost of most semiconductor materials. With increasing thin film manufacturing capacity and process yield improvements product costs are reduced.
Performance attributes: In addition to cost per watt advantages, thin film photovoltaic technologies exhibit performance advantages in generating energy in low light level and increased temperature environments. This positions them particularly well for applications in regions with less direct sunlight, such as in Northern Europe.

Day Start is trading near 52WK Lows, stock could Bounce back from this levels, keep an eye!
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney
we receive compensation from companies we feature. Always Read the full Disclosure/Disclaimer. Thanks.

Wednesday, February 1, 2012

CHGS, China Geng Sheng Minerals, Profile, Summary

Geng Sheng Minerals – CHGS - manufactures and markets a broad range of high-tech industrial material products, including monolithic refractories, industrial ceramics and fine precision abrasives. A market leader offering customized solutions.

Geng Sheng sells its products primarily to the iron and steel industry as heat-resistant components for steel-making furnaces, industrial kilns and other high-temperature vessels to guarantee and improve the productivity of those expensive pieces of equipment, while reducing their consumption of energy.

Geng Sheng's business is improving gradually, though at a very slow pace, as reported by the company. The stock is bouncing back from the 52WK LOWS, looks very interesting, keep an eye!

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney
we receive compensation from companies we feature. Always Read the full Disclosure/Disclaimer. Thanks.

Monday, January 23, 2012

Improving women's health and sex life, Bionovo, BNVI

Bionovo, BNVI, Profile, Summary
Bionovo (BNVI) a clinical-stage drug discovery and development company, focuses on the development drug candidates in the areas of women's health and cancer. The company's drug development process utilizes botanical sources used in traditional Chinese medicine to produce biologically active compounds.
Bionovo's lead drug candidate, Menerba, which completed phase 2 clinical trail and progressing into phase 3.
Improving Women’s Health
40 million women in America are of menopausal age, an estimated 75% to 85% experience significant and unpleasant side effects due to declining and fluctuating hormone levels. These problems include vaginal dryness, depression and weight gain. Existing therapies represent a multi-billion dollar market. Bionovo is striving to provide a safe, reliable, and clinically proven therapy to fill this unmet need.
The company also develops Bezielle, an oral anti-cancer agent that completed two separate phase 1 clinical trails for the treatment of advanced breast cancer. Seala, a preclinical drug candidate for the treatment of post-menopausal vulvar and vaginal atrophy.
Conquering Cancer
Breast cancer is the second leading cause of cancer deaths in the United States, and more than 200,000 new cases are diagnosed each year. As a result, breast cancer takes more than 40,000 lives annually.
The company successfully raised funds and appointed new executives and board members. The stock is trading near 52WK LOWS could bounce back, keep an eye!
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
we receive compensation from companies we feature. Always Read the full Disclosure/Disclaimer. Thanks.

Tuesday, January 17, 2012

Female Sexual Dysfunction, FSD

Female Sexual Dysfunction HOW BIG is the problem? And, How common is it? According to a recent study, conducted by the University of Chicago and published in the Journal of the American Medical Association, it apparently is a huge problem. 43% of women (aged 18 to 59) said they have experienced some degree of sexual dysfunction. A SMALL pharmaceutical company wants to change all that and want to level the playing field for Women! BioSante, BPAX, a specialist pharmaceutical company focused on Female health, wants to exploit the huge potential market opportunity. Men spent a whopping $5 Billion Dollars on Erectile Dysfunction drugs in 2011, according to the NY Times. BioSante's answer LibiGel! LibiGel is a transdermal testosterone gel in development for the treatment of Female Sexual Dysfunction – FSD -. BioSante has completed two Phase III LibiGel safety and efficacy trials and is conducting a Phase III cardiovascular event and breast cancer safety study. The company is planning to submit a new drug application to the FDA by year-end 2012. BioSante is an equal opportunity company, at least, when it comes to making money, so the company doesn't want to miss the rising demand from men. For men BioSante is developing, Bio-T-Gel™ , a once-daily transdermal testosterone gel for the treatment of male hypogonadism, or low testosterone levels. Low testosterone affects more than 4 to 5 million men in the U.S, according to the company. Is there are Gel for that? stock holders wish there was one. The Stock fell to the bottom gracelessly, still embarrassed and some what shameful, trading around its 52WK LOWS. We see a short to medium term bounce-back opportunity. Keep an eye. Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!® we receive compensation from companies we feature. Always Read the full Disclosure/Disclaimer. Thanks.

Tuesday, January 10, 2012

Reddy ice warming up| RDDY | Profile | Summary

Reddy Ice Warming up! RDDY

Reddy Ice- RDDY - is the largest manufacturer and distributor of packaged ice products in the United States, Reddy Ice has the geographic presence, infrastructure and capacity necessary to meet the multi-state demands of a diverse customer base in its served markets. The Company has built relationships with strong and loyal customers by providing a high level of service and quality at competitive prices, utilizing its extensive network of ice manufacturing plants and distribution centers.

Serving a variety of customer locations in 31 states and the District of Columbia under the Reddy Ice brand name, the Company's principal product is ice packaged in seven-to-fifty pound bags, with the ten pound bags being the primary ice product, principally sold to convenience stores and supermarkets. Additionally, sales are generated from its proprietary equipment, The Ice Factory machines, which are located in high volume sites that produce, package and store ice through an automated, self-contained process.

Slowly rising from 52WK LOWS, Bounce Back Short to Medium term opportunity, Keep an Eye!
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
we receive compensation from companies we feature. Always Read the full Disclosure/Disclaimer. Thanks.

Tuesday, January 3, 2012

Westinghouse, WEST, Profile, Summary

Westinghouse Solar (WEST) is a designer and manufacturer of solar power systems. The company's award-winning patented solar panel technology reduces the parts count by 80% and labor costs by 50% relative to ordinary panels, while improving aesthetics, safety and performance. The company has over 25 pending or issued patents related to solar panel installation technology. They sell their products across multiple channels that currently include a growing one-step distribution network of Westinghouse Solar Authorized Dealers throughout US, Canada and Puerto Rico; as well as through retail at the Lowe's Home Improvement stores, and OEM partnerships with companies such as leading HVAC equipment manufacturers. 1. Award winning products with strong IP protection 25+ pending or issued patents related to solar panel installation technology AC System recognized as a Breakthrough Product of the Year by Popular Mechanics. "Fully Integrated Solar System Moving Industry Toward True Plug-and-Play Solar Power" 2. Highly recognized and valued brand name Exclusive worldwide rights for Westinghouse Solar brand Westinghouse brand stands for trust and reliability Westinghouse brand accelerates customer adoptions through homeowner, retail and installer distribution channels 3. Rapidly growing sales channels One-Step Dealer Distribution Network - Westinghouse Solar Authorized Dealer network covering U.S., Canada and Puerto Rico Retail - Lowe's Home Improvement stores nationwide Various OEM relationships Bouncing back from 52WK LOWS, great short to medium term bounce back play, keep an eye! Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!® we receive compensation from companies we feature. Always Read the full Disclosure/Disclaimer. Thanks.